CAM
Cormorant Asset Management’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1M | Sell |
1,600,000
-400,000
| -20% | -$17.3M | 5.15% | 3 |
|
|
2025
Q1 | $69.1M | Buy |
2,000,000
+400,000
| +25% | +$13.8M | 5.2% | 3 |
|
|
2024
Q4 | $43.9M | Sell |
1,600,000
-258,351
| -14% | -$7.09M | 2.41% | 11 |
|
|
2024
Q3 | $47.3M | Hold |
1,858,351
| – | – | 2.51% | 13 |
|
|
2024
Q2 | $47.1M | Sell |
1,858,351
-1,344,678
| -42% | -$34.1M | 2.72% | 11 |
|
|
2024
Q1 | $99M | Sell |
3,203,029
-141,150
| -4% | -$4.36M | 4.34% | 5 |
|
|
2023
Q4 | $135M | Sell |
3,344,179
-1,318,351
| -28% | -$53.2M | 6.45% | 4 |
|
|
2023
Q3 | $123M | Buy |
4,662,530
+493,351
| +12% | +$13M | 7.17% | 2 |
|
|
2023
Q2 | $71.7M | Sell |
4,169,179
-388,235
| -9% | -$6.68M | 4.02% | 5 |
|
|
2023
Q1 | $75.6M | Buy |
4,557,414
+3,188,235
| +233% | +$52.9M | 4.98% | 6 |
|
|
2022
Q4 | $10.4M | Sell |
1,369,179
-100,000
| -7% | -$762K | 0.7% | 37 |
|
|
2022
Q3 | $14.6M | Hold |
1,469,179
| – | – | 1.02% | 34 |
|
|
2022
Q2 | $13.3M | Sell |
1,469,179
-99,730
| -6% | -$906K | 1.01% | 32 |
|
|
2022
Q1 | $15.9M | Sell |
1,568,909
-100,000
| -6% | -$1.01M | 1.22% | 23 |
|
|
2021
Q4 | $27.8M | Sell |
1,668,909
-100,000
| -6% | -$1.67M | 1.66% | 21 |
|
|
2021
Q3 | $82.9M | Sell |
1,768,909
-112,071
| -6% | -$5.25M | 3.37% | 7 |
|
|
2021
Q2 | $115M | Sell |
1,880,980
-287,929
| -13% | -$17.6M | 3.9% | 4 |
|
|
2021
Q1 | $134M | Sell |
2,168,909
-96,853
| -4% | -$5.97M | 2.98% | 4 |
|
|
2020
Q4 | $161M | Hold |
2,265,762
| – | – | 3.83% | 3 |
|
|
2020
Q3 | $85M | Sell |
2,265,762
-325,000
| -13% | -$12.2M | 3.27% | 4 |
|
|
2020
Q2 | $84.5M | Sell |
2,590,762
-359,238
| -12% | -$11.7M | 3.22% | 5 |
|
|
2020
Q1 | $85.6M | Buy |
2,950,000
+437,135
| +17% | +$12.7M | 3.98% | 3 |
|
|
2019
Q4 | $88.1M | Sell |
2,512,865
-104,701
| -4% | -$3.67M | 3.51% | 7 |
|
|
2019
Q3 | $56.2M | Sell |
2,617,566
-163,319
| -6% | -$3.51M | 3.42% | 5 |
|
|
2019
Q2 | $75M | Buy |
+2,780,885
| New | +$75M | 4.31% | 5 |
|